Form 4: Lemaitre Vascular Director Sells Shares Under 10b5-1 Plan

Lemaitre Vascular President and Director David B. Roberts sold 3,311.68 shares of common stock on March 11, 2026, at a weighted average price of $107.6752 per share.

Summary

• David B. Roberts, President and Director of Lemaitre Vascular Inc. (LMAT), reported a sale of common stock.
• The transaction involved the disposition of 3,311.68 shares of LMAT common stock.
• The sale occurred on March 11, 2026, at a weighted average price of $107.6752 per share.
• The shares were sold in multiple trades ranging from $106.52 to $108.65.
• Following this transaction, Mr. Roberts beneficially owns 14,667.32 shares of common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale was pre-scheduled under a Rule 10b5-1 plan, which typically indicates personal financial management rather than a reaction to new company-specific information, thus not signaling a strong positive or negative outlook.

Positives

• The transaction was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not a reaction to recent non-public information, which can reduce concerns about insider sentiment.

Negatives

• The sale represents a reduction in direct insider ownership by a key executive and director, which some investors may view with slight caution.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are common occurrences in the market. While a sale by a high-ranking executive like a President and Director might draw attention, the pre-arranged nature of a 10b5-1 plan typically suggests personal financial planning rather than a direct signal about the company's immediate operational performance or future prospects, distinguishing it from reactive insider selling.

Stakeholder Impact

• Shareholders: The sale by a key insider, even if planned, slightly reduces insider ownership, which some shareholders might monitor. However, the 10b5-1 plan mitigates concerns about the timing of the sale.

Key Dates

Keywords

LEMAITRE VASCULAR, LMAT, insider trading, Form 4, stock sale, David B. Roberts, 10b5-1 plan